Clinical Trial: Voriconazole as Prophylaxis for Liver Transplant Recipients

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Voriconazole as Prophylaxis for Liver Transplant Recipients

Brief Summary: The study aims to determine if voriconazole prevents invasive fungal infections in liver transplant recipients. Endpoints would be: occurrence of invasive fungal infection and fungal colonization. Two groups will be compared: patients who received voriconazole as prophylaxis and historical controls who did not receive this prophylaxis.

Detailed Summary: The following variables will be followed: time and location of positive cultures, underlying diseases and severity of illness, voriconazole usage prophylactically, physical exam findings, laboratory and radiographical data, antimicrobial usage, microbiological data and resistance patterns, choice of antifungal drugs once organism identified, suspected source of infection, microbiological outcomes, laboratory results, demographic information, medications, clinical outcome, gender, weight, ethnicity, and past medical history.
Sponsor: University of Pittsburgh

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Pittsburgh

Dates:
Date Received: September 13, 2005
Date Started: September 2005
Date Completion:
Last Updated: August 14, 2012
Last Verified: August 2012